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Abstract-The catalytic activities of hepatic microsomes from untreated, phenobarbital-treated and 3- 
methylcholanthrene-treated adult rabbits with respect to benzo[a]pyrene hydroxylation and the acti- 
vation of (-)truns-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene[( -)~ans-7,8-diol] to DNA-binding metab- 
olites were determined in the absence and presence of mixed-function oxidase inhibitors and compared 
to the corresponding activities of the individual enzyme systems. Treatment of rabbits with phenobarbital 
led to induction of P-450LMz and a concomitant 3-fold enhancement in microsomal benzo[a]pyrene 
hydroxylase activity, whereas the conversion of (-)rrans-7,8-diol to DNA-binding products was 
unaffected. Homogeneous phenobarbital-inducible P-450LM2 exhibited the highest activity and speci- 
ficity toward benzo[a]pyrene and the lowest activity toward (-)rrun.s-7,8-diol. Conversely, P-4SOLM4 
was the major form of cytochrome P-450 induced in rabbit liver by 3-methylcholanthrene or p- 
naphthoflavone, and this was associated in microsomes with an increase in the metabolism of (-)trans- 
7,8-diol but not of benzo[a]pyrene. Homogeneous P-450LM4 preferentially catalyzed the oxygenation 
of (-)tran.s-7,&diol, but was largely ineffective with benzo[n]pyrene. Partially purified P-450LM7 lacked 
substrate specificity, for it metabolized both benzo[a]pyrene and (-)trans-7.8-diol at comparable rates. 
Additionally, 7,8-benzoflavone strongly inhibited benzo[a]pyrene hydroxylation by P-450LM4 and 
phenobarbital-induced microsomes, as well as (-)trans-7,8-diol metabolism by P-450LM4 and 3-methyl- 
cholanthrene-induced microsomes; in contrast, the activity of control microsomes with either substrate, 
and the activities of P-450LM4 and LM2 with benzo[a]pyrene and (-)trans-7,8-dial, respectively, were 
only partially or slightly decreased by 7,8-benzoflavone. Unlike 7,8_benzoflavone, butylated hydroxy- 
toluene inhibited benzo[a]pyrene hydroxylation only. Thus, different forms of rabbit liver microsomal 
cytochrome P-450 were involved in the metabolism of benzo[n]pyrene and its 7,8_dihydrodiol. The 
results also demonstrate that the changes in substrate specificity and inhibitor sensitivity seen in 
phenobarbital- and 3-methylcholanthrene-induced microsomes relative to control rabbit liver micro- 
somes can be accounted for by the catalytic properties of a specific form of cytochrome P-450 that 
prevails in these preparations, P-450LMz and LM4, respectively. 
The hepatic microsomal cytochrome P-450-contain- 
ing mixed-function oxidases and related membrane- 
bound enzymes catalyze the oxidation of metaboli- 
* This research was supported by Grant AM-103339 from 
the United States Public Health Service and Grant PCM76- 
14947 from the National Science Foundation (to M. J. C.). 
t Present address: Istituto di Ricerche Farmacologiche 
“Mario Negri”, Via Critrea 62, Milano, Italy. 
11 Present address: Department of Pharmacology, North- 
western University Medical and Dental Schools, 303 East 
Chicago Ave., Chicago, IL 60611, U.S.A. 
tally important substances as well as a host of xeno- 
biotics [ 1,2]. Many foreign compounds are detoxi- 
fied by these versatile catalysts, while in other 
instances metabolism results in activation to cyto- 
toxic or carcinogenic species [3-S]. 
Following the resolution of the mixed-function 
oxidase system of liver microsomal membranes and 
reconstitution of an active hydroxylation system from 
the components, namely cytochrome P-450, 
NADPH-cytochrome P-450 reductase and phospha- 
tidylcholine [6,7], investigations in this laboratory 
focused on the separation and characterization of 
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multiple forms of rabbit P-450LM* (8, 91. PB-indu- 
cible P-450LMz and BNF-inducible P-450LMj were 
purified to homogeneity and shown to be distinct 
proteins, as judged by their physichochemical, 
immunological and kinetic properties [8-121. Addi- 
tional forms of rabbit P-450LM possessing different 
physical properties and catalytic activities, e.g. P- 
450LM,, LM3,, LM3,, and LM,. have been isolated 
in a partially purified state [8,9, 111. Several other 
laboratories have recently reported the separation 
and purification to varying extents of individual 
forms of the cytochrome from liver microsomes of 
untreated rats and rabbits, as well as from micro- 
somes of animals treated with different inducers [13- 
201. The existence of multiple forms of P-450LM. 
which exhibit different but often overlapping sub- 
strate specificities [8, 11, 14, 17, 18,20,21], provides 
a reasonable explanation for the remarkably broad 
substrate specificity of the liver microsomal 
hydroxylase system, while variations in the levels of 
the individual forms of the cytochrome can readily 
account for the differences in catalytic activity 
observed with microsomal suspensions from animals 
differing in age, sex, strain and type of inducer used 
for pretreatment. 
The biotransformation of the ubiquitous environ- 
mental pollutant BP, which is itself essentially non- 
toxic, proceeds by a number of pathways, some 
yielding biologically inactive products and some 
leading to the formation of highly reactive metab- 
olites which bind to cellular macromolecules and 
thus exert cytotoxic, mutagenic or carcinogenic 
effects [3, 22-251. The liver microsomal mixed-func- 
tion oxidase systems metabolize BP to phenols, qui- 
nones and unstable arene epoxide intermediates [26- 
291, which are further converted to dihydrodiols by 
epoxide hydrase [30,31]. Most of the oxygenated 
products appear in viva as water-soluble glutathione, 
glucuronic acid and sulfate conjugates [32-341. It is 
presently believed that the most significant pathway 
of BP activation, at least in 3-MC-induced rat liver 
microsomal suspensions, involves enzymatic oxy- 
genation of this polycyclic aromatic hydrocarbon in 
three remarkably stereospecific steps [3.5], ultimately 
giving rise to two stereoisomeric (-)trans-7,8-diol- 
9,10-epoxides, namely, a major dial-epoxide I and 
a minor dio-epoxide II in a ratio of about 10 to 1 
[35-371. The binding of reactive metabolites of BP 
and of other hydrocarbon carcinogens to DNA is 
highly correlated with the tumor-initiating ability of 
these compounds [38]. Although the binding of BP 
* The following abbreviations are used: P-45OLM, liver 
microsomal cytochrome P-450; BP, benzo[a]pyrene; (+) 
or (-)truns-7&diol, (+) or (-)truns-7,8-dihydroxy-7,8- 
dihydrobenzo[a]pyrene; diol-epoxide I, r-7,&dihydroxy- 
r-9.10-oxv-7.8,9,10-tetrahvdrobenzolalpvrene; diol-epox- 
ide II, ~r-7,t-8-dihydrox;-c-9,1O-oxy-~~,8,9,10-tetrahy.dro- 
benzo[a]pyrene; in the latter two abbreviations, r-7 indi- 
cates that the substituent at the 7-position is the reference, 
and I and c indicate that the substituents are tram and cis, 
respectively, to the reference substituent; 7,8-BF, 7&ben- 
zotlavone; BHT, butylated hydroxytoluene; AHH, aryl 
hydrocarbon hydroxylase; PB, phenobarbital; BNF, p- 
naphthoflavone; 3-MC, 3-methylcholanthrene; and dilau- 
royl-GPC, dilauroylglyceryl-3-phosphorylcholine. 
to DNA can occur via the K-region epoxides. e.g. 
by recycling of phenols such as Y- 
hydroxybenzo[a]pyrene through the mixed-function 
oxidase system [39-41], diol-epoxides I and II appear 
to be the predominant BP species bound to nucleic 
acids in vitro and in viva [4247] and the most 
mutagenic in cultured mammalian cells (diol-epoxide 
I) [48-501 and in strains TA 98 and TA 100 of 
Salmonella typhimurium (diol-epoxide II) [51]. 
In previous studies 152,531, we examined the 
metabolism of BP and of the two optical isomers of 
truns-7,8-diol by homogeneous and partially purified 
forms of rabbit P-450LM in the reconstituted enzyme 
system, using high pressure liquid chromatography 
to detect the metabolites formed. It was shown that 
BP is metabolized predominantly by P-450LM? [52], 
whereas the oxidation of (-)rran.s-7.8-dial is cata- 
lyzed twenty to thirty times faster by P-450LM, than 
LM2 [52, 531. Moreover, P-450LMJ exhibits a pro- 
nounced preference for the (-) as compared to the 
(+) enantiomer of trans-7,8-diol [53], and stereo- 
selectively converts the former to diol-epoxide I 
[52,53]. The striking stereospecificity of P-450LM, 
is also evident from the fact that this cytochrome 
inserts the oxygen atom primarily on one side of the 
plane of the trans-7,8-diol molecule, independent of 
the configuration of the 7.8 hydroxyl groups [53]. It 
follows that the relative distribution of the various 
forms of P-450LM in a tissue, coupled with the 
substrate specificity and the high degree of regio- 
and stereoselectivity of these catalysts, will most 
likely influence the metabolic disposition of a xeno- 
biotic substrate and thus regulate the balance 
between its detoxification and activation. 
In the present studies, we have investigated the 
effects of 7,8-BF, a strong inhibitor of BP metabolism 
and binding to DNA [54], and of two other com- 
pounds which may modulate chemical carcinoge- 
nesis, namely, BHT and ascorbic acid [55, 561, on 
BP and (-)trans-7,8-diol oxidation by control, PB- 
and 3-MC-induced rabbit liver microsomes, and by 
homogeneous P-450LM2 and LM, and partially pur- 
ified P-450LM, in the reconstituted enzyme system. 
The metabolism of BP was determined by the rapid 
and sensitive AHH assay, while the binding of 
(-)-trans-7,8-diol metabolites (diol-epoxides I and 
II) to DNA was used as an index of the catalytic 
activity of the various preparations toward (-)trans- 
7,8-dial. These studies may help in providing possible 
approaches to the modulation of chemical 
carcinogenesis. 
MATERIALS AND METHODS 
Treatment of animals and preparation of micro- 
somes for metabolism studies. Male New Zealand 
rabbits (l-l.2 kg in weight), obtained from the NIH 
animal supply, were treated, i.p., with 80mg PB 
(in 0.9% NaCl)/kg body wt once a day for 4 days, 
or treated one time with 40 mg 3-MC (in corn oil)/kg 
body wt; control animals received 0.9% NaCl or 
corn oil, respectively. The animals were killed 24 hr 
after the last injection, and the livers were hom- 
ogenized in 5 vol. of 0.05 M Tris-chloride buffer, pH 
7.5, containing 0.25 M sucrose. The microsomes 
were prepared as described previously 1291 and were 
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stored at -70”. Although there is some loss of activity 
upon freezing (Table 4)) no substantial loss of enzy- 
matic activity occurs during storage for a several- 
month period. The concentration of cytochrome P- 
450 in these preparations was determined from the 
spectrum of the reduced CO complex using an 
extinction coefficient of 91 mM_’ cm-’ for the dif- 
ference between A,,, (447-451 nm, depending on 
the preparation) and Ahw [57]. 
Treatment of animals and preparation of micro- 
somes for enzyme purification. Male New Zealand 
rabbits (2-2.4 kg in weight) were purchased from 
Langshaw Farms, Kalamazoo, MI, U.S.A. The 
animals were allowed to drink a 0.1% solution of 
sodium PB (adjusted with HCl to pH 7) for 5 days 
and were fasted for 16 hr. Other rabbits were given 
BNF (80 mg/kg body wt) by an intraperitoneal injec- 
tion of a 1% suspension in corn oil, and after 24 hr 
the animals were fasted for 16 hr [9]. The livers were 
homogenized in 4 vol. of 0.J M Tris-acetate buffer, 
pH 7.4, containing 0.1 M KCl, 1.0 mM EDTA and 
0.023 mM BHT, in a Waring Blendor for two 40-set 
intervals, and the mixture was centrifuged at 10,000 g 
for 30 min [58]. Liver microsomes were prepared, 
extracted with 0.1 M sodium pyrophosphate buffer 
containing 1.0 mM EDTA (in the absence of gly- 
cerol) and stored at -20” in the presence of glycerol 
[9]. The microsomes were subsequently thawed, 
solubilized with sodium cholate, and fractionated 
with polyethylene glycol as described previously 
[9,581. 
Purification of microsomal enzymes. The various 
forms of P-450LM are designated by their relative 
mobilities when submitted to discontinuous poly- 
acrylamide gel electrophoresis in the presence of 
sodium dodecylsulfate and fi-mercaptoethanol 
[8,9, 111. Ouchterlony diffusion analysis and sodium 
dodecylsulfate-polyacrylamide gel electrophoresis 
have shown that PB-inducible P-450LMz is present 
in only trace amounts in microsomes from untreated 
and BNF-treated rabbits, whereas BNF-inducible P- 
450LM4 is present at significant levels in microsomes 
from untreated and PB-treated animals [8,11]. As 
reviewed elsewhere [ll, 59,601, and in agreement 
with the induction studies of Atlas et al. [61], P- 
450LM., preparations purified from these three 
sources [9], as well as from 3-MC-induced (P-448) 
[15,62] and 2,3,7,8-tetrachlorodibenzo-p-dioxin- 
induced rabbits (P-450~) [17], are essentially the 
same protein based on several independent lines of 
evidence [9,10, 12, 17, 21, 52, 62, 631. 
The purification of P-450LMz from liver micro- 
somes of PB-treated rabbits and of P-450LM4 from 
the same source, as well as from microsomes of BNF- 
treated animals, was carried out according to pro- 
cedures published previously [9,64]. These prep- 
arations were homogeneous as judged by sodium 
dodecylsulfate-polyacrylamide gel electrophoresis 
in the presence of p-mercaptoethanol. Partially pur- 
ified P-450LM,, which is present in all of the micro- 
somal preparations and is not known to be inducible, 
was isolated from microsomes of untreated animals 
[8,11] and contained traces of epoxide hydrase. The 
concentrations of P-450LM2 and LM4 were deter- 
mined from the absolute spectra of the reduced CO 
complexes using extinction coefficients of 110 
mM_’ cm-’ for P-450LMZ (Amax at 451 nm) and 110 
mM_’ cm-’ for P-450LM4 (A,,, at 488 nm) [9]. The 
concentration of P-450LM, was estimated from the 
spectrum of the reduced CO complex using an 
extinction coefficient of 91 mM_’ cm-’ for the 
absorbance difference between 450 and 490 nm [57]. 
The specific content of the purified P-450LM samples 
used in these studies was as follows (expressed as 
nmoles of P-450LM per mg of protein): P-450LM2, 
17.5; P-450LM4 from PB- and BNF-induced rabbits, 
14.4 and 13.1, respectively; and P-450LM7, 1.2. 
NADPH-cytochrome P-450 reductase was purified 
from liver microsomes of PB-treated rabbits by 
DEAE-cellulose ion exchange chromatography fol- 
lowed by affinity chromatography on 2’,5’-ADP- 
agarose by procedures [ll, 651 similar to those pre- 
viously described for the rat liver enzyme [ 11,66,67]. 
The resulting preparation was homogeneous, by 
sodium dodecylsulfate-polyacrylamide gel electro- 
phoresis, and catalyzed the reduction of 40 pmoles 
cytochrome clminlmg of protein in 0.3 M potassium 
phosphate buffer, pH 7.7, at 30”. One unit of the 
reductase is defined as the amount which catalyzes 
the reduction of 1.0 pmole cytochrome c/min under 
these conditions. The concentration of the reductase 
was determined from the absolute spectrum of the 
oxidized flavoprotein using an extinction coefficient 
of 21 mM-‘cm-’ at 456 nm [ll, 65,671. 
AHH assay of BP metabolism. The NADPH- 
dependent oxidation of BP by liver microsomal sus- 
pensions from untreated (control), PB- or 3-MC- 
treated rabbits, and by purified forms of rabbit P- 
450LM in the reconstituted enzyme system, was 
measured under aerobic conditions in the absence 
and presence of mixed-function oxidase inhibitors. 
The reaction mixtures, in a total volume of 0.5 ml, 
contained either intact microsomes (100 pg protein) 
or the following components added in the order 
indicated: 0.15 nmole P-450LM, 0.25 nmole (0.9 
units) NADPH-cytochrome P-450 reductase and 
16 pg dilauroyl-GPC which were mixed and equili- 
brated at room temperature for 5 min. Tris-chloride 
buffer (pH 8.5) (25 pmoles) and NADPH (0.13 
pmole) were then added, and the reactions were 
initiated with BP (5 nmoles added in 0.005 ml meth- 
anol). The final concentrations of the various mod- 
ifiers, when present, were as follows: 7,8-BF or BHT, 
0.1 mM (added in 0.005 ml methanol); and ascorbic 
acid, 10 mM (added in 0.01 ml water). Incubations 
were carried out at 37” for 15 min; the reactions were 
terminated by the addition of 1.0 ml acetone at 4”, 
and the mixtures were extracted with 3.0 ml hexane 
(spectrograde). Two-ml aliquots of the organic phase 
were added to 1.0 ml of 1.0 N NaOH, and the flu- 
orescence of the phenolic products (primarily 3- 
hydroxybenzo[a]pyrene) in the alkaline solution was 
measured with an Aminco-Bowman model SPF-500 
spectrophotofluorometer (AHH assay). A calibra- 
tion curve was constructed by extracting known 
amounts of 3-hydroxybenzo[a]pyrene from the 
reaction mixtures prepared in the absence of 
enzymes. 
Assay of DNA binding activity. The binding of 
(-)trans-7,8-diol metabolites to DNA was estimated 
by a modification of procedures published previously 
[68,69]. The composition of the reaction mixtures 
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was as described above for BP metabolism, except 
that calf thymus DNA (0.25 mg) was also included 
and BP was replaced by [3HJ(-)trans-7,8-diol (5 
nmoles added in 0.005 ml of a 9:l mixture of meth- 
anol-tetrahydrofuran). After incubation at 37” for 
15 min, the samples were placed on ice and extracted 
twice with 3.0 ml ethyl acetate to remove unbound 
substrate and metabolites. MgC12 (3 pmoles) was 
added to the aqueous phase which was subsequently 
increased to 1.0 ml in volume and extracted with 
0.9 ml of phenol reagent (600 g of phenol, 0.5 g of 
8_hydroxyquinoline, 75 ml of cresol and 55 ml of 
water). The resulting mixture was centrifuged at 
2000 r.p.m. for 20 min, and the DNA in the aqueous 
phase was precipitated with 3 vol. of ethanol at 4”. 
The precipitate was dissolved in 1.0 ml of a 1.0 M 
Tris-chloride-O.003 M MgClz solution, washed three 
times with 2.0ml ethyl acetate, and reprecipitated 
with 3 vol. of ethanol. The DNA was then hydrolyzed 
in 0.5 M perchloric acid (1.2 ml) at 80” for 15 min. 
After cooling the samples at room temperature, a 
0.5-ml aliquot of the hydrolysate was diluted with 
5.0 ml Aquasol and counted in a Beckman model LS 
8100 scintillation counter having a greater than 30 
per cent efficiency for 3H. Another 0.5-ml aliquot 
of the hydrolysate was analyzed for DNA content 
by the absorption at 260 nm, using a Gilford model 
2400 spectrophotometer. The DNA content was 
estimated by a modification of the method of Shack 
[70] in which 4Opg of native calf thymus DNA/ml 
has an Azm of 0.66 after a 22 per cent correction for 
the hyperchromic effect due to the perchloric acid 
hydrolysis. 
Other methods. Protein concentrations were deter- 
mined according to Lowry et al. [71] with correction 
for the effect of other components of the solutions 
[9]; bovine serum albumin served as the standard. 
The data represent the mean * S.D. of values 
obtained in at least two separate experiments with 
duplicate determinations in each experiment. Stu- 
dent’s t-test was used to establish the significance of 
differences between means. Unless indicated other- 
wise, P < 0.01 was chosen as the level of significance. 
Chemicals. Nonlabeled racemic trans-7,8-diol was 
synthesized through National Cancer Institute Con- 
tract Nol-CP-33387, and the pure (+) and (-) optical 
isomers were prepared by high pressure liquid 
chromatography as already described [35,72]. 
[3H]( -)trans-7,8-Diol was obtained by incubating 
liver microsomes from 3-MC-treated rats with 
[3H]BP (sp. act. 20-50 Ciinmole) in the presence of 
NADPH and oxygen [36,37]. The biosynthetic [3H]- 
(-)trans-7,8-diol thus formed was isolated by high 
pressure liquid chromatography [73] and diluted to 
an appropriate specific activity (300 nCi/nmole) with 
nonradioactive (-)trans-7,8-diol. BP was obtained 
from Eastman Organic Chemicals (Rochester, NY) 
and was recrystallized from ethanol. 7,8-BF and 
BHT were purchased from the Aldrich Chemical 
Company (Milwaukee, WI) and were recrystallized 
from methanol. Calf thymus DNA and ascorbic acid 
were from the Sigma Chemical Co. (St. Louis, MO). 
Table 1. Effects of modifiers on BP metabolism by purified forms of rabbit P-450LM and by intact liver 
microsome? 
Activity 
















60.3 5 3.4 13.2 -c 2.2 (78)t 16.4 + 1.9 (73) 35.8 t 2.4 (41) 
6.8 ‘- 0.4 5.1 + 0.5 (25) 5.2 2 0.4 (24) 3.7 f 0.5 (46) 
2.7 k 0.1 2.1 2 0.59: (22) 2.2 2 0.4# (19) 1.7 * 0.1 (37) 
40.2 -c 3.6 30.1 2 7.10 (25) 29.0 C 6.1 (28) 23.9 t 5.2 (41) 
28.5 t 3.611 19.1 k 1.6 (33) 23.0 t 4.2 (19) 18.3 + 3.1 (36) 
54.5 2 5.51) 27.1 2 2.2 (50) 13.4 k 2.2 (75) 25.0 ” 4.6 (54) 
* AHH activities were determined by incubating BP with rabbit liver microsomal suspensions or with 
purified forms of rabbit P-405LM (homogeneous P-450LM2 and LMJ or partially purified P-450LM7) 
in the reconstituted enzyme system. Reaction mixtures contained Tris-chloride buffer, pH 8.5 
(25 pmoles), BP (5 nmoles), NADPH (0.13 ,umole), and either intact microsomes from the indicated 
source (100 pg protein) or purified P-450LM (0.15 nmole) homogeneous NADPH-cytochrome P-450 
reductase (0.25 nmole), and dilauroyl-GPC (16 pg) in a total volume of 0.5 ml. Incubations were carried 
out for 15 min at 37”, and the phenolic metabolites formed were extracted into NaOH and estimated 
by spectrophotofluorimetry as described in Materials and Methods. When present, 7,8-BF, BHT and 
ascorbic acid were added at a final concentration of 0.1. 0.1 and 10 mM, respectively. The microsomes 
used in these metabolic studies had been stored at -70” following their isolation. All the values are 
significant at a value of P < 0.01 except where indicated otherwise. 
t The numbers in parentheses denote per cent inhibition of AHH activity. 
$ The P-450LM4 used was isolated from either BNF- or PB-treated animals as indicated. 
$ P<O.O5. 
11 The specific activities, expressed as pmoles products formedlminimg of protein, were 32.8 and 93.8, 
respectively, for control and PB-induced microsomes incubated in the absence of modifier. 
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Aquasol was purchased from New England Nuclear 
(Boston, MA). Synthetic dilauroyl-GPC was 
obtained in chloroform solution from Serdary 
Research Laboratories, London, Ontario, Canada; 
prior to use, the solvent was removed under nitrogen 
and a 1 mglml aqueous suspension was prepared by 
sonication. The source and preparation of other 
materials are given elsewhere [8,9]. 
RESULTS 
The metabolism of BP in liver microsomal sus- 
pensions and in the reconstituted enzyme system 
containing the different forms of P-450LM was 
determined by spectrofluorimetric estimation of the 
phenolic metabolites formed (AHH assay). The dif- 
ferential effects of selected mixed-function oxidase 
inhibitors on the catalytic activity of the purified P- 
450LM preparations and of microsomes from 
untreated and PB-treated rabbits toward BP are 
compared in Table 1. PB-inducible P-450LM2 cata- 
lyzed the conversion of BP to phenols about ten to 
twenty times faster than P-450LM4, while rates of 
BP hydroxylation by partially purified P-450LM, 
were somewhat intermediate to those obtained with 
P-450LMz and LM+ Although P-450LM4 from BNF- 
induced microsomes appears to have been more 
active than the corresponding preparation from PB- 
induced microsomes, the opposite was found in a 
previous study in which phenols and other metab- 
olites formed from BP were analyzed by high pres- 
sure liquid chromatography [52]. Small differences 
in the relative activities of the P-450LM, proteins 
isolated from different sources are invariably seen 
from one preparation to another regardless of the 
type of microsomes used as source, and may be due 
to the presence of varying amounts of apoenzyme 
or to differences in the composition of reaction mix- 
tures and in the incubation conditions employed [53]. 
However, there is presently no strong evidence sug- 
gesting that these preparations are significantly dis- 
similar, catalytically or otherwise [ 11,59: 601. In fact, 
the oxidation of BP was catalyzed at comparable 
rates by the various purified preparations of the 
polycyclic hydrocarbon-inducible form of rabbit P- 
450LM isolated in different laboratories, i.e. P- 
450LM4 from BNF- or PB-induced microsomes 
(Table 1) [52,59], P-448 from 3-MC-induced micro- 
somes [62] and P-450~ from 2,3,7,8-tetrachlorodi- 
benzo-p-dioxin-induced microsomes [17,60]. The 
three P-450LM4 enzymes, purified in this laboratory 
from different sources, were indistinguishable based 
on electrophoretic and spectral properties, identity 
of the COOH-terminal amino acids [9], immuno- 
chemical methods [lo] and catalytic activity toward 
a variety of substrates besides BP [ll, 21,591. 
Table 1 also shows that treatment of rabbits with 
PB led to an increase in microsomal BP hydroxylase 
activity, as reported previously by others [61]. More- 
over, the P-450LM2-mediated hydroxylation of BP 
was markedly inhibited by 7,8-BF and BHT, whereas 
only a 25 per cent loss in the activity of P-450LM, 
or LM, was observed in the presence of either of 
these compounds. The pronounced inhibitory effect 
of BHT and, to a smaller extent, of 7,8-BF on BP 
hydroxylation in PB-induced microsomes most likely 
reflects inhibition of P-450LM,; since this cyto- 
chrome is induced by PB, it possesses the highest 
activity and degree of specificity towards BP, and its 
BP hydroxylase activity is the most sensitive to 7,8- 
BF and BHT. On the other hand, the effect of 7,8- 
BF and BHT on BP metabolism in microsomes from 
untreated rabbits was considerably smaller, and sim- 
ilar in magnitude to that seen with purified P-450LMj 
and LM7. This finding is consistent with the obser- 
vation that microsomes from untreated rabbits con- 
tain significant amounts of all P-450LM forms, except 
for P-450LM2 which is present in only trace amounts 
[8,11]. In contrast to the differential effects of 7,8- 
BF and BHT, ascorbic acid displayed no selectivity, 
for it inhibited all preparations uniformly by about 
40 per cent. This indicates that ascorbic acid is not 
a specific inhibitor of a particular form of P-450LM 
in the BP hydroxylation reaction, but may affect 
overall activity by inhibiting electron transport or 
some step in the redox cycle of P-450LM, or possibly 
phenol formation from arene oxide intermediates. 
The activity of the various preparations from rab- 
bit liver toward (-)trans-7,8-diol, as well as the 
effects of inhibitors on this activity, are depicted in 
Table 2. The conversion of (-)truns-7,8-diol to iso- 
merit 9,10-epoxides which bind to DNA was cata- 
lyzed by P-450LM, at rates about 2-fold and lo-fold 
greater than those obtained with P-450LM4 and LM2, 
respectively. However, P-450LM, was devoid of sub- 
strate specificity since it was equally as active with 
the (-)truns-7,8-diol as with BP. Inspection of the 
activities shown in Tables 1 and 2 reveals that the 
specificity for (-)trans-7,8-diol in the reconstituted 
enzyme system resides essentially in P-450LM+ This 
conclusion is also supported by the results of a pre- 
vious study in which BP and (-)trans-7,8-diol metab- 
olites were measured directly by high pressure liquid 
chromatography [52]. 
As in the case of BP hydroxylation, 7,8-BF mark- 
edly inhibited those forms of P-450LM which were 
the most active toward (-)trans-7,8-diol, i.e. P- 
450LM4 and LM,, but did not have an appreciable 
effect on P-450LM2 which was largely incapable of 
catalyzing the oxygenation of this substrate (Table 
2). BHT, unlike 7,8-BF, did not act in this dual 
fashion, for the metabolism of (-)truns-7,8-diol as 
substrate. Ascorbic acid caused a striking decrease 
in the activity of P-450LM4 but inhibited the activities 
of P-450LM, and LM2 to a lesser extent. 
It may also be seen in Table 2 that the metabolism 
of (-)truns-7,8-diol in microsomes remained unal- 
tered following treatment of the animals with PB; 
this is contrary to the effect of this compound on 
microsomal BP hydroxylase activity. 7,8-BF 
inhibited both microsomal preparations by about 45 
per cent, probably by inhibiting the activities of P- 
450LM4 and LM,. In agreement with its lack of effect 
on the purified proteins, BHT did not inhibit 
(-)trurrs-7,8-diol metabolism in microsomes from 
untreated or PB-treated rabbits. 
BP hydroxylation and the binding of (-)truns-7,8- 
diol metabolites to DNA were also investigated in 
3-MC-induced microsomes, as illustrated in Table 
3. Whereas 3-MC treatment led to a decrease in the 
specific activity of microsomal BP hydroxylase, the 
binding of (-)truns-7,8-diol metabolites to DNA was 
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Table 2. Effects of modifiers on (-)truns-7,8-diol oxidation to DNA binding metabolites by purified 
forms of rabbit P-450LM and by intact liver microsomes* 
Activity 
















4.5 r 0.5 3.7 2 1.4 (18)$ 4.7 t 1.1 2.9 -r 0.4 (36) 
19.5 ? 5.6 5.9 f 1.8 (70) 21.3 _+ 4.8 3.5 _c 1.0 (82) 
24.9 2 0.2 3.2 * 0.2 (87) 28.6 f 6.2 6.1 2 0.4 (76) 
41.9 it 1.6 6.2 k 0.7 (85) 36.1 z!z 1.5 (14) 18.7 rt 1.3 (55) 
13.4 5 2.80 7.9 + 2.2 (41) 12.8 + 1.9 8.5 2 0.911 (37) 
11.0 ‘+- 1.1s 6.0 c 1.0 (45) 9.9 * 0.5 8.1 + I.811 (26) 
* The catalytic activity of the various preparations toward (-&ens-7,Sdiol was ascertained by 
measuring the binding to DNA of (-)fruns-7,8-diol metabolites formed upon incubation of the diol 
with microsomes (100 Fg protein) or with purified P-450LM (0.3 PM) in the reconstituted enzyme 
system. Conditions were identical to those described in Table 1, except that [‘HI-(-)rrans-7.8-diol (10 
KM) served as the substrate and the reaction mixtures contained calf thymus DNA (0.25 mg) in addition 
to the other components. Incubations were carried out for 15 min at 37” and the amount of (-)~runs- 
7,8-diol metabolites bound to DNA was determined as described in Materials and Methods. The 
microsomes used in these experiments had been stored at -70” following their isolation. All values are 
significant at a value of P < 0.01 except where indicated otherwise. 
t The final concentration of the various modifiers was as in Table 1. 
$ Numbers in parentheses indicate per cent inhibition of the binding of (-)rrans-7.&diol metabolites 
to DNA. 
§ The specific activities, expressed as pmoles metabolite boundiminlmg DNA/mg of protein, were 
15.4 and 18.9, respectiveIy, for control and PB-induced microsomes incubated in the absence of modifier. 
// P < 0.05. 
Table 3. Effects of modifiers on BP metabolism and (-)truns-7,8-diol oxidation to DNA binding 
metabolites catalyzed by liver microsomes from untreated and 3-MC-treated rabbits* 
Activity? 
With modifier$ 
Reaction assayed and 
source of microsomes 
Without 











36.7 -+ 0.1 26.4 -e 4.7 (28)§ 26.6 z!z 1.9 (28) 24.4 rt 3.3 (34) 
27.3 t 0.9 17.0 f 1.3 (38) 26.5 k 4.9 26.3 rt 4.2 
43.7 rt 6.0 17.4 I 1.3 (6O)Ii 39.9 + 0.7 29.5 L 5.8 (32) 
87.4 z?z 6.4 18.3 it 1.6 (79) 83.3 t 1.x 57.5 + 6.4 (34) 
* AHH and DNA binding activities were determined by incubating microsomes from the indicated 
source (100 pg protein) with BP (10 wM) or with [3H]-(-)trans-7,8-diol (10 FM) in the presence of calf 
thymus DNA (0.25 mg) under incubation conditions identical to those described in Tables 1 and 2, 
respectively. The phenolic products formed from BP and the binding of (-)trans-diol metabolites to 
DNA, which reflects the catalytic activity of these preparations toward (-)tmns-7&diol, were measured 
as described in Materials and Methods. The microsomes used in these experiments had been stored at 
-70” foliowing their isolation. 
t Activities are expressed as pmoles products formed/min/mg of protein (BP hydroxylation) or pmoles 
metabolite bound/min/mg DNA/mg of protein [(-)lruns-7,8-diol oxygenation]. 
j: The final concentration of the various modifiers was the same as in previous experiments and is 
given in Materials and Methods and Table 1. 
5 Numbers in parentheses indicate per cent inhibition of AHH activity or of the binding of (-)frans- 
7,8-diol metabolites to DNA. 
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Table 4. Effects of 7,8-BF on BP metabolism and (-)trans-7,8-diol oxidation 
to DNA binding metabolites by fresh and previously frozen liver microsomes 









Microsomes stored at -70 
Binding of (-)trans-7,8-diol 
metabolites to DNA 
Fresh microsomes 
Microsomes stored at -70 
49.2 87.4 (177)s 
28.5 19.1 (67) 
22.6 16.5 (73)§ 
13.4 7.9 (59) 
* Experimental conditions were as in Table 3. Product formation (BP) and 
the binding of (-)trans-7,8-diol metabolites to DNA were assayed as described 
in Materials and Methods. Microsomes were used within l-2 days of their 
isolation (fresh) or after they had been stored at -70” for several weeks. 
t Activities are expressed as pmoles products formed/min/nmole P-450LM 
(BP hydroxylation) or pmoles metabolite bound/min/mg DNA/nmole P-450LM 
[(-)rrans-7,8-diol oxygenation]. 
$ 0.1 mM. 
5 Numbers in parentheses are the per cent of control activities [AHH and 
binding to DNA of (-)trans-7,8-diol metabolites, respectively] obtained in the 
absence of 7,8-BF. 
twice as great in 3-MC-induced microsomes as in 
control microsomes. These effects are the opposite 
of those obtained with PB treatment. The extent of 
inhibition of BP and (-)fran.s-7,&diol oxygenation 
by 7,8-BF or BHT in 3-MC-induced microsomes was 
as expected from the effects of these compounds on 
the corresponding activities of P-450LM4 and LM,. 
Freezing and storage of microsomes from 
untreated rabbits at -70” resulted in a 40 per cent 
loss of both BP hydroxylase activity and the binding 
of (-)trans-7,8-diol metabolites to DNA (Table 4), 
indicating that labile forms of P-450LM may have 
been present in these preparations. 7,8-BP stimu- 
lated BP hydroxylation about 2-fold in fresh micro- 
somes, but inhibited this activity by 30 per cent in 
microsomes stored frozen for several weeks. On the 
other hand, the binding of (-)truns-7,8-diol metab- 
olites to DNA was decreased by 7,8-BF in both 
preparations. The differential effect of 7,8-BF on BP 
hydroxylase activity suggests that one or more P- 
450LM forms were lost upon freezing and storage 
of control microsomes at -70”. 
DISCUSSION 
In the present studies we have examined the rela- 
tionship between individual purified forms of rabbit 
P-450LM and intact microsomes of different P- 
450LM composition in the metabolism of BP an! 
(-)trans-7,8-diol, and investigated the degree of 
selectivity of mixed-function oxidase inhibitors 
toward the various preparations catalyzing these 
reactions. It is well known that 7,8-BF produces a 
profound decrease in BP hydroxylase activity of 3- 
MC-induced rat liver microsomes [74], but only par- 
tially inhibits this activity in microsomes from adult 
3-MC- [75] (Table 3) or TCDD-treated rabbits [76]. 
On the other hand, stimulation of BP hydroxylation 
by 7,8-BF is seen in control microsomes from rats 
[74], adult rabbits [75,76] and humans [77]. BHT 
and similar phenolic antioxidants are capable of 
blocking the carcinogenic effects of a substantial 
number of polycyclic aromatic hydrocarbons in vivo, 
presumably by acting as scavengers of reactive 
metabolic species of the chemical carcinogens [78]. 
The inhibition of BP hydroxylation by BHT in vitro 
is believed to result from the direct interaction of 
this compound with cytochrome P-450 in liver micro- 
somes [55]. Ascorbic acid has been found to inhibit 
BP metabolism in rat liver microsomes [79] and to 
reduce dimethylbenzanthracene-initiated tumor for- 
mation when applied to mouse skin [56]. However, 
limited information is currently available concerning 
the role of these modifiers in the oxygenation of 
(-)truns-7,&diol by microsomes and by the recon- 
stituted enzyme system containing the different 
forms of P-450LM. 
Atlas et al. [61] have shown that certain com- 
pounds of the polycyclic aromatic hydrocarbon class 
exert essentially identical effects when administered 
to adult rabbits in vivo. Thus, 3-MC, BNF and 
2,3,7,8-tetrachlorodibenzo-p-dioxin induce micro- 
somal cytochrome P-448 (P-450LM4) to the same 
extent (about 2.5-fold), and either do not alter 
cytochrome P-448-associated mono-oxygenase activ- 
ities or, when induction is seen, give rise to com- 
parable increases in substrate hydroxylation rates 
[61]. Accordingly, the P-450LM4 proteins purified 
from microsomes of 3-MC- [15,62], BNF- [9] and 
2,3,7,8-tetrachlorodibenzo-p-dioxin-treated adult 
rabbits [17] are identical, as ascertained from elec- 
trophoretic, immunochemical and substrate speci- 
ficity studies [ll, 59,601. This is also true of P- 
450LM4 preparations isolated from PB-induced and 
control rabbit liver microsomes. These observations 
support the conclusion that it is both appropriate 
B.P. 29/12-E 
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and valid to explain the relative catalytic effective- 
ness of 3-MC-induced microsomes (Table 3) on the 
basis of the substrate specificity inherent in P- 
450LM4, regardless of the type of microsomes used 
as source for purification of this cytochrome (Tables 
1 and 2). 
It has been pointed out recently that the catalytic 
properties of microsomes should correspond to those 
of a specific form of P-450LM when that particular 
cytochrome predominates as a result of induction 
[59,76]. The findings in this paper clearly demon- 
strate that the changes in substrate specificity and 
inhibitor sensitivity seen with microsomes from PB- 
or 3-MC-treated rabbits do indeed reflect the preva- 
lence of a specific form of cytochrome P-450 in these 
preparations. In this regard, a single form of rabbit 
P-450LM, P-450LMZ, is induced to a predominant 
level by PB [8, 111, and this is accompanied by more 
than a 2-fold increase in microsomal BP hydroxylase 
activity; the oxygenation of (-)trans-7,8-dial 
remains unchanged in PB-induced, as compared to 
control, microsomes. In accordance with these 
results, P-450LM2 is fifteen to twenty times more 
active with BP than with (-)truns-7,8-diol and, of 
the several forms of P-450LM, has the highest speci- 
ficity toward BP. Furthermore, BHT and 7,8-BF 
inhibited BP hydroxylase activities of P-4S0LM2 and 
of PB-induced microsomes by 75 per cent, whereas 
no significant change in the metabolism of this sub- 
strate by control or 3-MC-induced microsomes and 
by purified P-450LMj or LM, was seen in the pres- 
ence of either of these compounds. 
Conversely, treatment of rabbits with 3-MC leads 
to an increase in the specific content of P-450LM4 
[15,59,62] and a concomitant 2-fold enhancement 
in the binding of (-)trans-7,8-diol metabolites to 
DNA, but has no effect on BP metaboIism in micro- 
somes; induction of P-450LM4 in adult rabbits by 
BNF [8-11,611 or 2,3,7,8-tetrachlorodibenzo-p- 
dioxin [17,60.61] is likewise not associated with an 
increase in microsomal BP hydroxylase activity 
[61,75]. Homogeneous P-450LMI possessed the 
highest specificity for (-)nuns-7,8-diol and catalyzed 
the oxygenation of this substrate five times faster 
than P-450LMr, but was largely ineffective with BP. 
In fact, P-450LMJ from PB- or BNF-induced micro- 
somes is by far the least active of the various forms 
of rabbit P-450LM in BP hydroxylation, whether 
activity is expressed in terms of total metabolites 
[52], or total phenols estimated fluorometrically 
(Table 1), or by high pressure liquid chromatography 
[52]. Similar results have been obtained with P- 
450LM4 preparations from 2,3,7,8-tetrachlorodi- 
be~o-~-dioxin-treated adult rabbits [17,60,76]. 
Moreover, 7,8-BF strongly inhibited (-)trans-7,8- 
diol oxygenation by P-450LM4 and 3-MC-induced 
microsomes and caused a considerable diminution 
of this activity in control microsomes, which are 
known to contain P-450LM4 at significant levels 
[8,11]. However, in contrast to 7,8-BF, inhibitor 
selectivity appears to be the sole property of BHT 
since this compound did not alter (-)truns-7,8-diol 
oxygenation in any of the microsomal preparations 
or in the reconstituted enzyme system containing the 
different forms of P-450LM. In other experiments 
(not shown) treatment of rabbits with 3-MC osten- 
sibly did not alter the overall activity of microsomes 
toward (-)trans-7,8-diol, as judged by the total 
metabolites formed, but a substantially greater 
amount of diol-epoxide I than diol-epoxide II was 
obtained with 3-MC-induced as compared to control 
microsomes. It is noteworthy in this connection that 
P-450LM4 exhibited a striking preference for the 
pure (-) relative to the (+) enantiomer of nuns-7.X- 
diol, and stereoselectively oxygenated the former to 
yield IO-fold more diol-epoxide I than dioi-epoxide 
II. These results provide strong evidence in favor of 
the view that the catalytic properties of each form 
of P-45OLM, as determined in reconstituted enzyme 
systems, are characteristic of and intrinsic to that 
form and by no means due to artifacts of the puri- 
fication or reconstitution techniques. 
In conclusion, our results demonstrate that the 
oxygenation of BP and BP(-)trans-7,8-diol is cata- 
lyzed by different forms of rabbit P-450LM, and that 
each of these processes is affected differently by 
mixed-function oxidase inhibitors. The data also 
illustrate that substrate metabolism in PB- and 3- 
MC-induced rabbit liver microsomes can be 
accounted for by the catalytic properties of the pre- 
dominant forms of P-450LM in these preparations, 
P-450LM2 and LM4, respectively. In sharp contrast 
to the results obtained with rabbit P-450LM. it is 
well established that BP and trans-7,8-diol oxygenase 
activities are both induced several-fold in micro- 
somes from rats treated with polycyclic aromatic 
hydrocarbons [SO]. Accordingly. rat 3-MC-inducible 
cytochrome P-448 is seven times more active than 
PB-inducible cytochrome P-450 with BP [SO] and 
approximately thirty times more active with racemic 
bans-7,8-diol[81]. The stereospecificity of individual 
forms of P-450LM, whose relative proportion in a 
given tissue is invariably altered by drugs and envi- 
ronmental pollutants and by hormonal and genetic 
factors, may play a key role in determining the 
balance between detoxification and activation; this, 
in turn, may govern the susceptibility of specific 
tissues and animals to the carcinogenic action of 
polycyclic hydrocarbons. 
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